rGLP-1 protein
(OGWAVGNOAMXIIM-VTAHJYCESA-N)
Structure
- SMILES
- NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)CCCNC(=N)N)CCCCN)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1nc[nH]c1)N)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C
- Molecular Formula:
- C148H223N39O46
- Molecular Weight:
- 3284.590
- Log P:
- 1.5392
- Hydrogen Bond Acceptor:
- 83
- Hydrogen Bond Donor:
- 49
- TPSA:
- 1379.3
- CAS Number(s):
- N/A
Synonym(s)
1.
rGLP-1 protein
2.
Eperzan
3.
Tanzeum
4.
albiglutide
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Nausea | FAERS: 13 | US FAERS | |
| 2 | Vomiting | FAERS: 13 | US FAERS | |
| 3 | Abdominal Pain | FAERS: 5 | US FAERS | |
| 4 | Cholecystitis | FAERS: 5 | US FAERS | |
| 5 | Angina Pectoris | FAERS: 3 | US FAERS | |
| 6 | Drug ineffective | FAERS: 3 | US FAERS | |
| 7 | Hypotension | FAERS: 3 | US FAERS | |
| 8 | Lipase increased | FAERS: 3 | US FAERS | |
| 9 | Malaise | FAERS: 3 | US FAERS | |
| 10 | Acute kidney injury | FAERS: 2 | US FAERS | |
| 11 | Cholelithiasis | FAERS: 2 | US FAERS | |
| 12 | Dizziness | FAERS: 2 | US FAERS | |
| 13 | Tachycardia | FAERS: 2 | US FAERS | |
| 14 | Urinary tract infection | FAERS: 2 | US FAERS | |
| 15 | Abdominal discomfort | FAERS: 1 | US FAERS | |
| 16 | Acute myocardial infarction | FAERS: 1 | US FAERS | |
| 17 | Arthralgia | FAERS: 1 | US FAERS | |
| 18 | Asthenia | FAERS: 1 | US FAERS | |
| 19 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 20 | Autoimmune thyroiditis | FAERS: 1 | US FAERS | |
| 21 | Back Pain | FAERS: 1 | US FAERS | |
| 22 | Bipolar Disorder | FAERS: 1 | US FAERS | |
| 23 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 24 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 25 | Blood urea increased | FAERS: 1 | US FAERS | |
| 26 | Cardiac Arrest | FAERS: 1 | US FAERS | |
| 27 | Chest Pain | FAERS: 1 | US FAERS | |
| 28 | Colitis | FAERS: 1 | US FAERS | |
| 29 | Constipation | FAERS: 1 | US FAERS | |
| 30 | Contraindicated drug prescribed | FAERS: 1 | US FAERS | |
| 31 | Diabetes mellitus inadequate control | FAERS: 1 | US FAERS | |
| 32 | Diplopia | FAERS: 1 | US FAERS | |
| 33 | Dysgeusia | FAERS: 1 | US FAERS | |
| 34 | Enteritis | FAERS: 1 | US FAERS | |
| 35 | Fatigue | FAERS: 1 | US FAERS | |
| 36 | Gastroenteritis | FAERS: 1 | US FAERS | |
| 37 | Headache | FAERS: 1 | US FAERS | |
| 38 | Hydronephrosis | FAERS: 1 | US FAERS | |
| 39 | Hypothyroidism | FAERS: 1 | US FAERS | |
| 40 | Oliguria | FAERS: 1 | US FAERS | |
| 41 | Pain | FAERS: 1 | US FAERS | |
| 42 | Pancreatitis | FAERS: 1 | US FAERS | |
| 43 | Peripheral arterial occlusive disease | FAERS: 1 | US FAERS | |
| 44 | Post procedural complication | FAERS: 1 | US FAERS | |
| 45 | Pulmonary Hypertension | FAERS: 1 | US FAERS | |
| 46 | RET gene mutation | FAERS: 1 | US FAERS | |
| 47 | Rash erythematous | FAERS: 1 | US FAERS | |
| 48 | Renal tubular necrosis | FAERS: 1 | US FAERS | |
| 49 | Squamous cell carcinoma | FAERS: 1 | US FAERS | |
| 50 | Sudden death | FAERS: 1 | US FAERS | |
| 51 | Syncope | FAERS: 1 | US FAERS | |
| 52 | Urticaria | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.